These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 9244390)

  • 61. Biological significance of polymorphism in legume protease inhibitors from the Bowman-Birk family.
    Clementea A; Domoney C
    Curr Protein Pept Sci; 2006 Jun; 7(3):201-16. PubMed ID: 16787260
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells.
    Xia HZ; Du Z; Craig S; Klisch G; Noben-Trauth N; Kochan JP; Huff TH; Irani AM; Schwartz LB
    J Immunol; 1997 Sep; 159(6):2911-21. PubMed ID: 9300715
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure.
    Selwood T; McCaslin DR; Schechter NM
    Biochemistry; 1998 Sep; 37(38):13174-83. PubMed ID: 9748324
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase.
    Cregar L; Elrod KC; Putnam D; Moore WR
    Arch Biochem Biophys; 1999 Jun; 366(1):125-30. PubMed ID: 10334872
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor.
    Pemberton AD; Huntley JF; Miller HR
    Biochim Biophys Acta; 1998 Jan; 1379(1):29-34. PubMed ID: 9468329
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors.
    Schechter NM; Sprows JL; Schoenberger OL; Lazarus GS; Cooperman BS; Rubin H
    J Biol Chem; 1989 Dec; 264(35):21308-15. PubMed ID: 2592376
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rat serosal mast cell degranulation mediated by chymase, an endogenous secretory granule protease: active site-dependent initiation at 1 degree C.
    Schick B; Austen KF
    J Immunol; 1986 May; 136(10):3812-8. PubMed ID: 2939135
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides.
    Scarpi D; McBride JD; Leatherbarrow RJ
    J Pept Res; 2002 Feb; 59(2):90-3. PubMed ID: 11906611
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis of a mixture of cyclic peptides based on the Bowman-Birk reactive site loop to screen for serine protease inhibitors.
    Domingo GJ; Leatherbarrow RJ; Freeman N; Patel S; Weir M
    Int J Pept Protein Res; 1995 Jul; 46(1):79-87. PubMed ID: 7558601
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chymase and tryptase in dog mastocytoma cells: asynchronous expression as revealed by enzyme cytochemical staining.
    Caughey GH; Viro NF; Calonico LD; McDonald DM; Lazarus SC; Gold WM
    J Histochem Cytochem; 1988 Aug; 36(8):1053-60. PubMed ID: 3134486
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The biochemical and functional food properties of the bowman-birk inhibitor.
    Losso JN
    Crit Rev Food Sci Nutr; 2008 Jan; 48(1):94-118. PubMed ID: 18274967
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells.
    Ware JH; Wan XS; Kennedy AR
    Nutr Cancer; 1999; 33(2):174-7. PubMed ID: 10368813
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [High molecular weight soy isoinhibitors of the Bowman-Birk type. Isolation, characteristics, and kinetics of interaction with proteinases].
    Gladysheva IP; Sharafutdinov TZ; Larionova NI
    Bioorg Khim; 1994 Mar; 20(3):281-9. PubMed ID: 8166755
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors.
    He S; Gaça MD; Walls AF
    Eur J Pharmacol; 2001 Feb; 412(3):223-9. PubMed ID: 11166285
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
    Ekrami H; Kennedy AR; Witschi H; Shen WC
    J Drug Target; 1993; 1(1):41-9. PubMed ID: 8069543
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interaction of murine intestinal mast cell proteinase with inhibitors (serpins) in blood; analysis by SDS-PAGE and western blotting.
    Irvine J; Newlands GF; Huntley JF; Miller HR
    Immunology; 1990 Jan; 69(1):139-44. PubMed ID: 2312150
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR
    Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cleavage of a rat serosal mast cell membrane component during degranulation mediated by chymase, a secretory granule protease.
    Schick B
    Immunology; 1990 Mar; 69(3):423-8. PubMed ID: 2312165
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Purification of mast cell proteases from murine skin.
    Algermissen B; Laubscher JC; Bauer F; Henz BM
    Exp Dermatol; 1999 Oct; 8(5):413-8. PubMed ID: 10536969
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Comparison of biochemical properties of human airway tryptase isolated from mucoid sputum with those of lung mast cell tryptase].
    Yasuoka S; Tsuchihashi S; Kurokawa M; Terao T; Yoshinaga T; Kawano S; Takekawa Y; Nakayama T; Doi H; Ogawara M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):678-84. PubMed ID: 8741534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.